Pfizer Begins Spinoff Of Animal Health Business

Law360, New York (June 7, 2012, 2:27 PM EDT) -- Pfizer Inc. on Thursday made good on its promise to spin off or sell its animal health business, announcing the formation of a new company, Zoetis, which it will take public by next July.

The move follows the $11.85 billion sale of its infant nutrition unit to Nestle SA in April as the world's biggest drugmaker looks to squeeze more growth from its core biopharmaceutical division. New York-based Pfizer had been exploring options, including spinoffs and sales, for both units since last summer.

It said it...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.